NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has reported encouraging topline results from its Phase 1 trial of ...

A pair of new studies on COVID-19 antiviral drugs suggest that resistance mutations that emerge after treatment with ...

New data published yesterday in Morbidity and Mortality Weekly Report (MMWR) show older adults continue to be hospitalized ...

Ratutrelvir was well-tolerated for 10 days and achieved consistent plasma levels in the predicted therapeutic window, without the need for ...

In a study of 52 people with long COVID, lithium aspartate at 10 to 15 mg/day yielded no significant improvement in fatigue ...

A new COVID variant, XEC, has arrived just before fall. The new variant has sprouted from the Omicron variant that developed ...

The days of quarantine and strict social distancing are over, but the CDC still has some recommendations for how to act if ...

Oral Paxlovid (nirmatrelvir-ritonavir) is highly effective at preventing hospitalization and death from COVID-19, yet it has been remarkably underused, even by patients at highest risk from COVID-19, ...

Europe has announced a €2 million project to research long COVID, following €100 million already invested since 2021. Is all ...

What to avoid with this at-home COVID-19 treatment Paxlovid is a combination antiviral medication that contains nirmatrelvir (a protease inhibitor) and ritonavir (originally used to treat HIV ...

As quantum computing companies look for sectors where their technology can have the earliest and largest possible impact, ...

A new COVID-19 variant, XEC, has arrived just before fall. The new variant has sprouted from the omicron variant that ...